Cargando…

Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA

Chronic airways infection with methicillin-resistant Staphylococcus aureus (MRSA) is associated with worse respiratory disease cystic fibrosis (CF) patients. Ceftaroline is a cephalosporin that inhibits the penicillin-binding protein (PBP2a) uniquely produced by MRSA. We analyzed 335 S. aureus isola...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varela, Maria Celeste, Roch, Melanie, Taglialegna, Agustina, Long, Scott W., Saavedra, Matthew Ojeda, Rose, Warren E., Davis, James J., Hoffman, Lucas R., Hernandez, Rafael E., Rosato, Roberto R., Rosato, Adriana E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582194/ https://www.ncbi.nlm.nih.gov/pubmed/33093601 http://dx.doi.org/10.1038/s42003-020-01313-5

Ejemplares similares

Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients
por: Roch, Melanie, et al.
Publicado: (2018)

VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Infection
por: Taglialegna, Agustina, et al.
Publicado: (2019)

Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
por: Barber, Katie E., et al.
Publicado: (2014)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

1367. Reduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s HospitalReduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s Hospital
por: Sommer, Lauren, et al.
Publicado: (2020)

Targeting of PBP1 by β-lactams Determines recA/SOS Response Activation in Heterogeneous MRSA Clinical Strains
por: Plata, Konrad B., et al.
Publicado: (2013)

Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms
por: Lázaro-Díez, María, et al.
Publicado: (2016)

Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints
por: Sachu, Arun
Publicado: (2023)

PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK
por: Harrison, Ewan M., et al.
Publicado: (2016)

Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
por: McCreary, Erin K, et al.
Publicado: (2019)

Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost
por: Roch, Melanie, et al.
Publicado: (2017)

Exposure of Clinical MRSA Heterogeneous Strains to β-Lactams Redirects Metabolism to Optimize Energy Production through the TCA Cycle
por: Keaton, Mignon A., et al.
Publicado: (2013)

TCA Cycle-Mediated Generation of ROS Is a Key Mediator for HeR-MRSA Survival under β-Lactam Antibiotic Exposure
por: Rosato, Roberto R., et al.
Publicado: (2014)

Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
por: Morroni, Gianluca, et al.
Publicado: (2021)

Ceftaroline
por: Soriano, Alex
Publicado: (2021)

A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
por: Lounsbury, Nicole, et al.
Publicado: (2019)

1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection
por: Barlow, Ashley, et al.
Publicado: (2021)

Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013–2014 at the Geneva University Hospitals
por: Andrey, D. O., et al.
Publicado: (2016)

Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia with Ceftaroline Fosamil in a Patient with Inhalational Thermal Injury
por: Faris, Janie, et al.
Publicado: (2015)

A host for redondoviruses
por: Taglialegna, Agustina
Publicado: (2022)

Across the mucus
por: Taglialegna, Agustina
Publicado: (2022)

SURFing SARS-CoV-2 inhibition
por: Taglialegna, Agustina
Publicado: (2023)

1315. Ceftaroline Versus Vancomycin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis in Adults
por: Esquivel, Marc, et al.
Publicado: (2021)

Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA
por: Gonzales, Patrick R., et al.
Publicado: (2015)

Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of Dalbavancin Alone and in Combination with Ceftaroline against Methicillin-Resistant Strains (MRSA) of Staphylococcus aureus
por: Kebriaei, Razieh, et al.
Publicado: (2017)

1624. Real World Experience with Daptomycin (DAP) and Ceftaroline (CPT) Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia
por: Zidaru, Andrei, et al.
Publicado: (2020)

174. Impact of Ceftaroline Duration after Bacteremia Clearance When Used in Combination Therapy for Persistent or High-grade MRSA Bacteremia
por: Cabanilla, M Gabriela, et al.
Publicado: (2023)

Synergistic Inhibition of MRSA by Chenodeoxycholic Acid and Carbapenem Antibiotics
por: Cui, Kaiyu, et al.
Publicado: (2022)

472 Ceftaroline-induced Neutropenia: Two Case Reports
por: Martin, Kelly E., et al.
Publicado: (2014)

2403. Comparison of Daptomycin Combination Therapy With Ceftaroline or Oxacillin Against Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Causing Persistent Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

204. Clinical Outcomes with Ceftaroline Monotherapy versus Daptomycin-Ceftaroline Combination Therapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Andonie, Gabriela, et al.
Publicado: (2021)

2059. Comparative Evaluation of Ceftaroline Susceptibility Methods in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA): Results from a Multicenter Study
por: Rivas, Lina M, et al.
Publicado: (2018)

1597. Evaluation of Ceftaroline Resistance (CPT-R) in Chile Across Time and a Comparison of CLSI vs. EUCAST Breakpoints in Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Khan, Ayesha, et al.
Publicado: (2019)

Ceftaroline-related acute eosinophilic pneumonia
por: Min, Zaw, et al.
Publicado: (2021)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

A Case of Ceftaroline-Associated Thrombocytopenia
por: Jagadish, Ashwin, et al.
Publicado: (2023)

Staphylococcus pseudintermedius’s PBP4 Is Directly Associated with the Dissociated Oxacillin and Cefoxitin Phenotype
por: Gagetti, Paula, et al.
Publicado: (2021)

Antimicrobial Synergistic Effects of Linezolid and Vancomycin with a Small Synthesized 2-Mercaptobenzothiazole Derivative: A Challenge for MRSA Solving
por: Muraglia, Marilena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cjidfu0l7u9a4ct1sgpqdd3kko